Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NanoEcho AB (publ)OSTO:NANECH PB Ratio is 0.91 as of Jul. 24, 2026, which is 9% below its 10-year median of 1.00. The stock has 1 warning sign investors should review. Among 1,229 Biotechnology companies, NanoEcho AB (publ) ranks better than 83.97% on this metric.
The historical rank and industry rank for NanoEcho AB (publ)'s PB Ratio or its related term are showing as below:
OSTO:NANECH'
s PB Ratio Range Over the Past 10 Years
Min: 0.57 Med: 1 Max: 1.57
Current: 0.91
During the past 4 years, NanoEcho AB (publ)'s highest PB Ratio was 1.57. The lowest was 0.57. And the median was 1.00.
OSTO:NANECH's PB Ratio is ranked better than 83.97% of 1229
companies
in the Biotechnology industry
Industry Median: 2.79
vs OSTO:NANECH: 0.91
During the past 12 months, NanoEcho AB (publ)'s average Book Value Per Share Growth Rate was -51.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -10.50% per year.
During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of NanoEcho AB (publ) was -10.50% per year. The lowest was -10.50% per year. And the median was -10.50% per year.
Back to Basics: PB Ratio
NanoEcho AB (publ) (OSTO:NANECH) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
NanoEcho AB (publ) PB Ratio Related Terms
NanoEcho AB (publ) PB Ratio Historical Data
* Premium members only.
The historical data trend for NanoEcho AB (publ)'s PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:NANECH vs VRTX, REGN, ALNY: PB Ratio Comparison
For the Biotechnology subindustry, NanoEcho AB (publ)'s PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NanoEcho AB (publ) PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NanoEcho AB (publ)'s PB Ratio distribution charts can be found below:
* The bar in red indicates where NanoEcho AB (publ)'s PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
NanoEcho AB (publ) (OSTO:NANECH) has a PB Ratio of 0.91 as of Jul. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on NanoEcho AB (publ) and its competitors. This is near median its historical median of 1.00. Over the past decade, NanoEcho AB (publ)'s PB Ratio has ranged from 0.57 to 1.57. According to the industry distribution chart, NanoEcho AB (publ) ranks #197 out of 1229 companies in the Biotechnology industry, placing it in the top 16%.
Is NanoEcho AB (publ)'s PB Ratio too high?
NanoEcho AB (publ)'s current PB Ratio of 0.91 is near median its 10-year median of 1.00. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 1.57. The Biotechnology industry median PB Ratio is 2.79. NanoEcho AB (publ)'s value of 0.91 is 67.4% below this industry median. Based on the distribution chart, NanoEcho AB (publ) ranks #197 out of 1229 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does NanoEcho AB (publ)'s PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, NanoEcho AB (publ) ranks #197 out of 1229 companies for PB Ratio. This places NanoEcho AB (publ) in the top 16% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.79. NanoEcho AB (publ)'s value of 0.91 is 67.4% below this benchmark. Historically, NanoEcho AB (publ)'s own PB Ratio has ranged from 0.57 to 1.57 over the past decade. While the company's 10-year median is 1.00 vs. the industry median of 2.79, NanoEcho AB (publ) has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.79, based on 1,229 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NanoEcho AB (publ)'s current PB Ratio of 0.91 is 67.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on NanoEcho AB (publ) and its competitors. For the Biotechnology industry, the median PB Ratio is 2.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NanoEcho AB (publ)'s current PB Ratio is 0.91, which is near median its own 10-year median of 1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NanoEcho AB (publ) stock overvalued right now?
NanoEcho AB (publ) (OSTO:NANECH) has a current PB Ratio of 0.91. The current PB Ratio is 0.91, which is near median its 10-year median of 1.00 and 67.4% below the Biotechnology industry median of 2.79. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For NanoEcho AB (publ) (OSTO:NANECH), the current PB Ratio is 0.91 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NanoEcho AB (publ) is a Swedish medical technology company. The company is developing a new diagnostic method to track rectal cancer's effect on nearby lymph nodes for the generation of health economic gains. The company's imaging technology is based on a new medical method where nanotechnology is combined with modern ultrasound technology to improve diagnosis methods.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:NANECH has been successfully added to your 
